Background: Emerging carbapenem resistance among Acinetobacter baumannii clinical isolates is a worldwide problem. Infections caused by A. baumannii are increasing and demonstrate high mortality rates. This study aimed to establish a nationwide surveillance of antimicrobial susceptibility, carbapenemase genes, and clonal relationships of A. baumannii clinical isolates in Taiwan. Methods: Clinical isolates of Acinetobacter calcoaceticuseA. baumannii (ACB) complex collected by the Taiwan Surveillance of Antimicrobial Resistance-V program between July 2006 and September 2006 were used in this study. Genospecies identification was verified by 16S-23S rRNA intergenic-spacer sequences. Carbapenemase genes were detected by polymerase chain reaction. Pulsed-field gel electrophoresis and multilocus sequence typing (MLST) was applied for identification of clonal relationships. Results: Among the 151 ACB-complex isolates collected, 134 (88.7%) were A. baumannii, 12 (8.0%) were A. pittii, and five (3.3%) were A. nosocomialis. A. baumannii isolates showed higher resistance rates to ciprofloxacin, amikacin, and ampicillin/sulbactam than A. pittii or A. nosocomialis (all p < 0.001). The most commonly detected carbapenemase genes were * Corresponding author. Department of Internal Medicine, National Taiwan University Hospital, 7 Chung-Shan South Road, Taipei 100, Taiwan.
Introduction
Acinetobacter baumannii is a major emerging pathogen causing healthcare-associated infections. 1 Carbapenem is the drug of choice for managing A. baumannii infections 2 ; however, the occurrence of carbapenem resistance in A. baumannii (CRAB) isolates is increasing worldwide, 3 ranging from 10% to 70% depending on the country or region. 2 Acinetobacter genospecies 1 (A. calcoaceticus), genospecies 2 (A. baumannii), genospecies 3 (A. pittii), and genospecies 13TU (A. nosocomialis) are phenotypically similar and are referred to as the A. calcoaceticuseA. baumannii (ACB) complex strains. 4 Genospecies 1 is considered an environmental pathogen, as opposed to causing healthcare-associated infections, 5 and A. baumannii causes more severe diseases than the other genospecies. 6 Therefore, surveillance and determination of the different genospecies among the ACB-complex strains in areas with high ACB-complex prevalence rates is important.
In this study, clinical isolates collected from the Taiwan Surveillance of Antimicrobial Resistance (TSAR-V) study 7 were analyzed. We aimed to establish nationwide epidemiology data on carbapenem resistance and carbapenemase genes and also to determine the disease burden of the different genospecies. In Taiwan, there is an increasing rate of carbapenem resistance. However, whether there were clonal spread was not identified. Pulsed-field gel electrophoresis (PFGE) was used for typing the A. baumannii isolates 8 in order to identify if there were dominant clones circulating in Taiwan. Multilocus sequence typing (MLST) 9 was used to determine the relationship between the international lineages and the isolates in Taiwan.
Methods

Hospital setting and bacterial isolates
The Taiwan Surveillance of Antimicrobial Resistance (TSAR) program was initiated in 1998 by the National Health Research Institutes, Taiwan, to monitor the trends and spectrum of antimicrobial resistance in Taiwan. The program collected nonduplicate sequential clinical isolates from inpatients and outpatients from 25 medical centers and regional hospitals around Taiwan over a 3-month period every 2 years. The 25 participating hospitals included nine medical centers and 16 regional hospitals; seven were located in northern Taiwan, eight in western Taiwan, seven in southern Taiwan, and three in eastern Taiwan. In this study, 151 nonduplicate ACB-complex isolates of various clinical specimens from the 25 hospitals participating in the TSAR program from July 2006 to September 2006 (TSAR-V) were collected. 7 This research conformed to the Helsinki Declaration and local legislation. The samples were taken as part of standard care. The Institutional Review Board of National Taiwan University Hospital waived the investigation process according to the local legislation since all the samples were analyzed anonymously and only bacteria isolates were examined.
Bacterial identification
ACB-complex strains were identified using biochemical methods. 10 Genospecies were identified according to the sequence of the 16Se23S rRNA gene intergenic spacer region, as previously described.
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Susceptibility testing
Minimum inhibitory concentrations (MICs) of amikacin, ciprofloxacin, imipenem, ampicillin/sulbactam, tigecycline, and colistin were determined using agar dilution methods. Susceptibility was interpreted according to the criteria of the Clinical and Laboratory Standards Institute. 12 The MIC breakpoint for tigecycline susceptibility was based on the FDA breakpoint for Enterobacteriaceae of 2 mg/L. 13 
Analysis of carbapenem resistance genes
Bacteria DNA was extracted as previously described. 11 Primers used in this study are listed in Table 1. 14,15 Metallo-b-lactamase genes, bla IMP and bla VIM , and carbapenem hydrolyzing class D b-lactamase (CHDL) genes, bla OxA-51 -like, bla OxA-58 -like, bla OxA-23 -like, and bla OxA-24 -like, were detected using polymerase chain reaction methods. 16 PFGE and multilocus sequence typing PFGE of ApaI-digested genomic DNA from each ACBcomplex isolate was performed to detect the relationships among the clinical isolates. 8, 17 PFGE patterns were compared using the software package Gel Compare II (Applied Maths BVBA, Austin, TX, USA), and unweighted pair-group mean analysis dendrograms were constructed from these data. Isolates with a Dice coefficient of similarity > 80% were considered clusters of possibly related isolates. 17, 18 MLST was based on a sequence analysis of the internal portions of seven housekeeping genes (cpn60, fusA, gltA, pyrG, recA, rplB and rpoB). The MLST scheme including amplification and sequencing primers, allele sequences and sequence types (STs) are available at Institut Pasteur's MLSTWeb site (http://www.pasteur.fr/recherche/ genopole/PF8/mlst/references_Abaumannii.html).
Statistical analysis
Categorical data were compared using Fisher's exact test, and p < 0.05 was defined as statistically significant. For multiple comparisons, posthoc analysis using Fisher's exact test utilizing a Bonferroni-adjusted a for pair-wise comparisons was employed if the initial Fisher's exact test was statistically significant. Data were analyzed using Stata software, version 10 (StataCorp, College Station, TX, USA).
Results
Genospecies distribution of the ACB-complex isolates
There were a total of 151 clinical ACB-complex isolates collected, which included 21 isolates (13.9%) from eastern Taiwan, 38 (25.2%) from northern Taiwan, 55 (36.4%) from western Taiwan, and 37 (24.5%) from southern Taiwan. Most of the isolates were collected from sputum (66, 43.7%), wounds (26, 17.2%), urine (23, 15.2%), or blood (18, 11.9%). Among the isolates collected, 134 (88.7%) were A. baumannii, 12 (8.0%) were A. pittii, and five (3.3%) were A. nosocomialis ( Table 2) .
The antimicrobial susceptibility rates to ciprofloxacin, amikacin, and ampicillin/sulbactam of A. baumannii isolates were 19.4%, 24.6%, and 50%, respectively. The A. baumannii isolates showed higher ciprofloxacin, amikacin, and ampicillin/sulbactam resistance than the A. pittii isolates (all p < 0.001) and also showed higher ciprofloxacin and amikacin resistance than the A. nosocomialis isolates (p < 0.001 and p Z 0.018, respectively) ( Table 3 ). The susceptibility rates to imipenem, tigecycline, and colistin of A. baumannii isolates were 80.6%, 77.6%, and 100%, respectively. All A. baumannii isolates showed susceptibility to colistin (MIC 2 mg/L; Fig. 2A ). Among the 26 CRAB isolates, the susceptibility rates to amikacin, ciprofloxacin, and ampicillin/sulbactam were 0%, 0%, and 23.1%, respectively. Furthermore, CRAB and carbapenemsusceptible A. baumannii isolates showed that tigecycline susceptible rates were 69.2% and 79.6%, respectively, while the A. pittii and A. nosocomialis isolates all showed 100% susceptible to tigecycline. However, if an MIC cut-off point of 1 mg/L was applied, 19 the tigecycline susceptibility rates of CRAB and carbapenem-susceptible A. baumannii isolates dropped to 15.4% and 36.7%, respectively (Table 4 , Fig. 2B ). A. baumannii isolates also showed significantly lower susceptibility rates to tigecycline than the A. pittii and A. nosocomialis isolates if an MIC cut-off point of 1 mg/L was applied (32.1% vs. 91.7%, p < 0.001, and 32.1% vs. 100%, p Z 0.004, respectively). 19 
Identification of carbapenem-resistance genes
Among the 151 ACB-complex isolates, 135 harbored the bla OxA-51 -like gene. All of the 134 A. baumannii isolates had 
PFGE analysis and antimicrobial susceptibility among pulsotype clusters
All 151 ACB-complex isolates underwent PFGE analysis. Among them, 51 isolates belonged to one of three major pulsotype clusters. In total, 12 (8%) isolates belonged to pulsotype 4, 26 (17.2%) belonged to pulsotype 5, and 13 (8.6%) belonged to pulsotype 7 (Table 6 ). Isolates belonged to these three major pulsotypes were found throughout Taiwan, including 42.8% of isolates from eastern Taiwan, 40% of isolates from western Taiwan, 15.8% of isolates from northern Taiwan, and 37.8% of isolates from southern Taiwan. All isolates of three major clones were A. baumannii. The other 100 ACB-complex isolates were distributed among 72 other pulsotypes (Fig. 1) . All five A. nosocomialis and 12 A. pittii isolates belonged to different Table 6 ). There were differences in antimicrobial resistance patterns among the major clones. Pulsotype 4 showed 100% ciprofloxacin and amikacin resistance, which is significantly higher than other the nonmajor pulsotypes (other than pulsotypes 4, 5, and 7; p Z 0.032 and p Z 0.007, respectively). Pulsotypes 5 and 7 also had higher resistance rates for ciprofloxacin and amikacin compared to the other nonmajor pulsotypes (p < 0.001, p < 0.001 for ciprofloxacin and p Z 0.017, p Z 0.004 for amikacin, respectively). Pulsotype 5 also showed higher ampicillin/ sulbactam resistance (p Z 0.013), and pulsotype 7 exhibited higher tigecycline resistance (p Z 0.035) relative to the other nonmajor pulsotypes (Table 6) .
MLST
The 51 A. baumannii isolates of the major clones (pulsotypes 4, 5, and 7) were selected for MLST to find out the relationship between major clones in Taiwan and the international lineages. Fifty isolates were typable, and all had ST2 (2-2-2-2-2-2-2), which seems to be the typical ST of EU clone II. 20 
Discussion
In this nationwide surveillance study, we demonstrated the distribution of the different genospecies of ACBcomplex isolates and also showed the resistance and the carbapenemase gene distributions among these isolates. There were three dominant clusters of A. baumannii identified, which showed higher antimicrobial resistance rates for ciprofloxacin, amikacin, and ampicillin/sulbactam and were widely distributed around Taiwan hospitals. These major clones had ST2 and belonged to EU clone II.
Isolates of A. baumannii showed an increasing trend of resistance in Taiwan. TSAR-II in 2000 showed that only 2% of isolates were resistant to imipenem and the resistance rates for ciprofloxacin and amikacin were 69% and 63%, respectively. 7 Resistance rates for imipenem, ciprofloxacin, and amikacin were significantly higher in TSAR-V isolates collected in 2006 than those of TSAR-II isolates (imipenem resistance 19.4% vs. 2%, p < 0.001; ciprofloxacin resistance Table 5 Distribution of carbapenem resistance genes among the different genospecies 24 showed that bla OxA-58 were the major CHDL genes in the CRAB isolates in their studies. However, in this nationwide surveillance of ACB-complex isolates, metallob-lactamase and CHDL genes other than bla OxA-51 were rarely found. Although not surprising, isolates with both bla OxA-23 -like or bla OxA-24 -like and bla OxA-51 genes showed higher carbapenem resistance, which is consistent with previous reports. 24, 25 Nevertheless, among the 26 CRAB isolates, only two had the bla OxA-23 -like gene and two had the bla OxA-24 -like gene, and there were no bla OxA-58 -like, bla IMP , or bla VIM genes identified.
In this study, there were three major clusters of related isolates circulating in Taiwan. These isolates were more resistant to ciprofloxacin, amikacin, and ampicillin/ sulbactam as well as tigecycline. Horizontal transmission of antimicrobial resistance genes and clonal spreading under antimicrobial selection could explain these observations. 9, 17 Our findings support clonal spreading as an important factor influencing antimicrobial resistant A. baumannii transmission, and this might be the cause of increased amikacin and ciprofloxacin resistance among CRAB isolates observed over the past few years.
Tigecycline is considered as an alternative antimicrobial agent for treating infections caused by CRAB. 2 In this study, CRAB isolates showed tigecycline susceptibility of 69.2%. If an MIC cut point of 1 mg/L was applied, 2, 19 the tigecycline susceptibility rate of CRAB isolates drop to 15.4% (Table 4 , Fig. 2B ). Because the serum levels of tigecycline are low and mean concentrations are only 0.63 mg/L, 1 our findings infer that tigecycline monotherapy should be used cautiously, Figure 1 . Dendrograms based on PFGE types for Acinetobacter baumannii complex isolates. especially in cases of severe infections, such as bloodstream infections. Furthermore, genospecies identification and MIC confirmation should be considered under these circumstances.
Our study provides the possible explanation that the increase of the multidrug resistant A. baumannii in Taiwan may be due to clonal spread. However, there are limitations in this study. First, since the TSAR program was a microbiology surveillance program, no clinical data were available. As such, we cannot analyze the clinical impact of different clusters of A. baumannii isolates, and most of the isolates were acquired from nonsterile site, so the impact of resistance on clinical practice should be interpreted cautiously. Second, although our previous study had showed that ISAba1-bla OxA51 , gyrA mutation, and integron were associated with imipenem, fluoroquinolones, and aminoglycosides resistance, 16, 26, 27 resistance genes other than CHDLs, bla IMP , and bla VIM were not evaluated in this study. Thus, even though possible A. baumannii clonal spreading with higher resistance was identified, whether the same resistance mechanism was involved was not clear. Third, while we included nationwide isolates, including those from medical centers and regional hospitals, the number of isolates is still relatively small, and might not be representative of all situations in Taiwan. Further investigations with more isolates are needed. This study demonstrated clonal spreading of dominant A. baumannii isolates in Taiwan and that these clones were more resistant to multiple antimicrobial agents. This might explain the high prevalence of CRAB and the continuing increase in CRAB infections in Taiwan. As predominant clusters showed more resistance to various antimicrobial agents, efforts to prevent and control of A. baumannii infections and prudent use of antibiotics in Taiwan should be emphasized.
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